157695-66-4

Upstream product

• 23632-66-8 (4S)-3-benzyloxycarbonyl-4-carboxymethyl-1,3-oxazolidin-5-one 
• 111197-44-5 (4S)-4-(Chloroformyl)methyl-3-[(phenylmethoxy)carbonyl]oxazolidin-5-one 
• 134038-91-8 1-<(S)-3-benzyloxycarbonyl-5-oxo-4-oxazolidinone>-3-diazo-2-propanone 
• 118553-53-0 rac-tert-butyl 2-<(benzyloxy)carbonylamino>-2-(dimethoxyphosphoryl)-acetate 
• 142683-57-6 tert-butyl (S)-2-benzyloxycarbonylamino-4,5-dihydroxy-2-pentenoate 
• 142683-56-5 tert-butyl (S)-2-benzyloxycarbonylamino-4,5-isopropylidenedioxy-2-pentenoate 
• 142683-58-7 tert-butyl (S,Z)-2-benzyloxycarbonylamino-5-tert-butyldimethylsiloxy-4-hydroxy-2-pentenoate 
• 142683-60-1 tert-butyl (S)-2-benzyloxycarbonylamino-5-tert-butyldimethylsiloxy-4-oxopentanoate 
• 142683-59-8 tert-butyl (2S,4S)-2-benzyloxycarbonylamino-5-tert-butyldimethylsiloxy-4-hydroxypentanoate 

Downstream Products

• 26911-39-7 (S)-2-amino-5-hydroxy-4-oxopentanoic acid 

Relevant academic research and scientific papers

SYNTHESIS OF CHIRAL LACTAMS AS TEMPLATES FOR ENZYME INHIBITORS: AN UNUSUAL ANNULATION IN THE INTRAMOLECULAR WADSWORTH-HORNER-EMMONS REACTION

Intramolecular carbonylolefination of a dipeptide keto phosphonate furnished unexpected lactams through rearrangement of the phosphonate carbanion.

Stereoselective syntheses of the antibiotics (+)-negamycin and (-)-HON (RI-331)

The stereoselective syntheses of the antibiotics (-)-HON (5-hydroxy-4-oxo-L-norvaline, RI-331) and (+)-negamycin starting from (S)-4-[(Z)-2-(benzyloxycarbonylamino)-2-(tert-butoxycarbonyl)vinyl]-2, 2-dimethyl-1,3-dioxolane and (R)-3-benzyloxycarbonyl-5-[(Z)-2-(tert-butoxycarbonylamino)-2-(methoxy carbonyl) vinyl]-2,2-dimethyl-1,3-oxazolidine, respectively, are described.